Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Apex Orthopedics, LLC currently manages 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are assigned to 3 distinct examiners. All 3 examiners are situated within 1 distinct art unit, concentrating the company's prosecution within a single technical group. This concentration within 1 distinct art unit allows the company to navigate a single set of administrative guidelines while receiving feedback from 3 distinct examiners.
GANESAN, SUBA is the busiest examiner, holding 1 busiest examiner pending office action. This accounts for one of the 3 pending office actions. The presence of 3 distinct examiners within only 1 distinct art unit suggests that while the administrative oversight is centralized, the company is receiving varied feedback from multiple examiners on its medical device claims. Practitioners should coordinate responses to ensure that arguments made to GANESAN, SUBA do not conflict with those presented to the other examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GANESAN, SUBA | 1 | 73.8% | +13.4% |
| MATHEW, SEEMA | 1 | 71.4% | +26.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18459038 | Arthrodesis Dowel Implant and Methods for Treating Mid-Foot Orthopedic Disorders | MATHEW, SEEMA | 23d overdue |
| 18459042 | Orthopedic Joint Arthroplasty Devices, Systems, and Methods for Treating Mid-Foot Disorders | GANESAN, SUBA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18459038 | Arthrodesis Dowel Implant and Methods for Treating Mid-Foot Orthopedic Disorders | MATHEW, SEEMA | 23d overdue |
| 18459042 | Orthopedic Joint Arthroplasty Devices, Systems, and Methods for Treating Mid-Foot Disorders | GANESAN, SUBA | — |
| Art Unit | Apps |
|---|---|
| 3774 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18459042 | Orthopedic Joint Arthroplasty Devices, Systems, and Methods for Treating Mid-Foot Disorders | GANESAN, SUBA | 3774 | §102§103 | Non-Final OA | — | Pending | Aug 30, 2023 |
| 18459038 | Arthrodesis Dowel Implant and Methods for Treating Mid-Foot Orthopedic Disorders | MATHEW, SEEMA | 3774 | §102§103 | Final Rejection | 23d overdue | Pending | Aug 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial